DuoGenic StemCells (ROCO:7607) Scaled Net Operating Assets : 0.35 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

DuoGenic StemCells's operating assets for the quarter that ended in Jun. 2024 was NT$39.47 Mil. DuoGenic StemCells's operating liabilities for the quarter that ended in Jun. 2024 was NT$6.75 Mil. DuoGenic StemCells's Total Assets for the quarter that ended in Dec. 2023 was NT$94.00 Mil. Therefore, DuoGenic StemCells's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.35.

DuoGenic StemCells Scaled Net Operating Assets Historical Data

The historical data trend for DuoGenic StemCells's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Scaled Net Operating Assets Chart

DuoGenic StemCells Annual Data

Trend

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.27

0.45

0.48

DuoGenic StemCells Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial			-	-	0.46	0.35	0.35

Competitive Comparison of DuoGenic StemCells's Scaled Net Operating Assets

For the Biotechnology subindustry, DuoGenic StemCells's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DuoGenic StemCells's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DuoGenic StemCells's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where DuoGenic StemCells's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

DuoGenic StemCells Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

DuoGenic StemCells's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(47.706	-	8.415)	/	82.24
=	0.48

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	94.002	-	46.296
=	47.706

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	15.582	-	5.228	-	1.939
=	8.415

DuoGenic StemCells's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(39.47	-	6.748)	/	94.002
=	0.35

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	59.785	-	20.315
=	39.47

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	13.661	-	4.727	-	2.186
=	6.748

DuoGenic StemCells Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN

Website

https://www.dgsc.com.tw

DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines